neuroClues closes €10M Series A to bring its eye-tracking Parkinson’s diagnostic to European and US neurologists
The Next Web
Read the full article
NeuroClues secured €10 million in Series A funding to advance its eye-tracking technology for Parkinson's diagnosis, aiming to expand access among neurologists in Europe and the US. The funding will support clinical trials and regulatory approvals to bring this diagnostic tool to market.
